
Agenus/LinkedIn
Aug 20, 2025, 07:10
Excited to Announce our Upcoming Virtual Stakeholder Briefing – Agenus
Agenus shared a post on LinkedIn:
“We are excited to announce our Virtual Stakeholder Briefing on Wednesday, August 27, 2025, at 4:00 PM ET.
Join us to hear from our leadership team, including Founder & CEO Garo H. Armen, PhD, and leading oncology experts from Duke University and the Canadian Cancer Trials Group. The agenda will cover:
- Strategic and Q2 2025 financial overview
- Achievements towards Zydus partnership closing, advancing botensilimab (BOT) and balstilimab (BAL)
- Launch of the pivotal Phase 3 BATTMAN study in metastatic colorectal cancer (CRC)
- Patient-driven innovations and upcoming immuno-oncology milestones
Register for the webcast.
Webcast link.”
More posts featuring Agenus.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 20, 2025, 07:10
Aug 19, 2025, 20:14
Aug 19, 2025, 20:05
Aug 19, 2025, 20:04
Aug 19, 2025, 19:53
Aug 19, 2025, 19:47
Aug 19, 2025, 19:42
Aug 19, 2025, 19:25